These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 32463132
1. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells. Li ZF, Yao YD, Zhao YY, Liu Y, Liu ZH, Hu P, Zhu ZR. J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132 [Abstract] [Full Text] [Related]
2. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Zhou Y, Su J, Shi L, Liao Q, Su Q. Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092 [Abstract] [Full Text] [Related]
7. PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed Patients. Zhang J, Song Y, Ahn AR, Park HS, Park SH, Moon YJ, Kim KM, Jang KY. Cells; 2024 Aug 28; 13(17):. PubMed ID: 39273017 [Abstract] [Full Text] [Related]
9. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1. Tan Y, Hu H, Tan W, Jin L, Liu J, Zhou H. Mol Med Rep; 2016 Nov 28; 14(5):4422-4428. PubMed ID: 27665963 [Abstract] [Full Text] [Related]
10. Rho A Regulates Epidermal Growth Factor-Induced Human Osteosarcoma MG63 Cell Migration. Wang J, Zhang L, Qu R, Zhang L, Huang W. Int J Mol Sci; 2018 May 11; 19(5):. PubMed ID: 29751634 [Abstract] [Full Text] [Related]
11. The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells. Jin PY, Lu HJ, Tang Y, Fan SH, Zhang ZF, Wang Y, Li XN, Wu DM, Lu J, Zheng YL. Biomed Pharmacother; 2017 Dec 11; 96():1324-1334. PubMed ID: 29203385 [Abstract] [Full Text] [Related]
12. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion. Cai S, Ye Z, Wang X, Pan Y, Weng Y, Lao S, Wei H, Li L. J Exp Clin Cancer Res; 2015 May 15; 34(1):48. PubMed ID: 25975262 [Abstract] [Full Text] [Related]
13. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Ahmed T, Shea K, Masters JR, Jones GE, Wells CM. Cell Signal; 2008 Jul 15; 20(7):1320-8. PubMed ID: 18424072 [Abstract] [Full Text] [Related]
17. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer. Zhao CC, Zhan MN, Liu WT, Jiao Y, Zhang YY, Lei Y, Zhang TT, Zhang CJ, Du YY, Gu KS, Wei W. Cancer Lett; 2020 Nov 28; 493():120-127. PubMed ID: 32829006 [Abstract] [Full Text] [Related]
18. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo. Yang W, Shan Z, Zhou X, Peng L, Zhi C, Chai J, Liu H, Yang J, Zhang Z. Cancer Biomark; 2018 Nov 28; 23(4):589-601. PubMed ID: 30475755 [Abstract] [Full Text] [Related]
19. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways. Ren T, Zheng B, Huang Y, Wang S, Bao X, Liu K, Guo W. Cell Death Dis; 2019 Mar 18; 10(4):261. PubMed ID: 30886151 [Abstract] [Full Text] [Related]
20. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines. Zhang HS, Zhao JW, Wang H, Zhang HY, Ji QY, Meng LJ, Xing FJ, Yang ST, Wang Y. Mol Med Rep; 2014 Jan 18; 9(1):103-8. PubMed ID: 24247826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]